Sodium stibogluconate
Sodium stibogluconate is a medication used primarily in the treatment of leishmaniasis, a disease caused by protozoan parasites of the genus Leishmania. It is an antimonial compound, which means it contains the element antimony. Sodium stibogluconate is administered by injection and is considered one of the main treatments for leishmaniasis, particularly in regions where the disease is endemic.
Chemical Composition and Properties
Sodium stibogluconate is a pentavalent antimonial compound. Its chemical formula is C12H38N3NaSb2O26. The compound is a complex of antimony with gluconic acid, which helps to increase its solubility and bioavailability.
Mechanism of Action
The exact mechanism of action of sodium stibogluconate is not fully understood. However, it is believed to interfere with the energy metabolism of the Leishmania parasites. The drug inhibits the enzyme trypanothione reductase, which is crucial for the parasite's defense against oxidative damage. This leads to the accumulation of toxic substances within the parasite, ultimately causing its death.
Medical Uses
Sodium stibogluconate is primarily used to treat various forms of leishmaniasis, including:
The drug is administered via intravenous or intramuscular injection, typically over a period of 20 to 30 days. The dosage and duration of treatment may vary depending on the severity of the infection and the specific type of leishmaniasis.
Side Effects
Common side effects of sodium stibogluconate include:
- Nausea
- Vomiting
- Fatigue
- Myalgia (muscle pain)
- Arthralgia (joint pain)
Serious side effects can include:
History
Sodium stibogluconate has been used in the treatment of leishmaniasis since the early 20th century. It was one of the first effective treatments for the disease and remains in use today, although newer treatments have been developed.
Related Pages
- Leishmaniasis
- Antimony
- Trypanothione reductase
- Cutaneous leishmaniasis
- Visceral leishmaniasis
- Mucocutaneous leishmaniasis
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD